Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.Commun Biol. 2020 Oct 08; 3(1):570.CB
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Links
Pub Type(s)
Published Erratum
Language
eng
PubMed ID
33033409
Citation
Simpson, Benjamin S., et al. "Author Correction: Genetic Alterations in the 3q26.31-32 Locus Confer an Aggressive Prostate Cancer Phenotype." Communications Biology, vol. 3, no. 1, 2020, p. 570.
Simpson BS, Camacho N, Luxton HJ, et al. Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype. Commun Biol. 2020;3(1):570.
Simpson, B. S., Camacho, N., Luxton, H. J., Pye, H., Finn, R., Heavey, S., Pitt, J., Moore, C. M., & Whitaker, H. C. (2020). Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype. Communications Biology, 3(1), 570. https://doi.org/10.1038/s42003-020-01291-8
Simpson BS, et al. Author Correction: Genetic Alterations in the 3q26.31-32 Locus Confer an Aggressive Prostate Cancer Phenotype. Commun Biol. 2020 Oct 8;3(1):570. PubMed PMID: 33033409.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
AU - Simpson,Benjamin S,
AU - Camacho,Niedzica,
AU - Luxton,Hayley J,
AU - Pye,Hayley,
AU - Finn,Ron,
AU - Heavey,Susan,
AU - Pitt,Jason,
AU - Moore,Caroline M,
AU - Whitaker,Hayley C,
Y1 - 2020/10/08/
PY - 2020/10/9/entrez
PY - 2020/10/10/pubmed
PY - 2020/10/10/medline
SP - 570
EP - 570
JF - Communications biology
JO - Commun Biol
VL - 3
IS - 1
N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper.
SN - 2399-3642
UR - https://www.unboundmedicine.com/medline/citation/33033409/Author_Correction:_Genetic_alterations_in_the_3q26_31_32_locus_confer_an_aggressive_prostate_cancer_phenotype_
DB - PRIME
DP - Unbound Medicine
ER -